Strong Blood, Marrow Transplant Unit Gets Prestigious Accreditation
Wednesday, October 20, 2004
Gordon L. Phillips II, M.D.
Strong Memorial Hospital’s Blood and Marrow Transplant Program received recognition for its high quality care with a re-accreditation from the Foundation for the Accreditation of Cellular Therapy.
The program gained a three-year re-accreditation for all types of blood and marrow transplant procedures – both allogeneic and autologous -- as well as its collection and cell processing procedures. The Strong program was first accredited in 2000.
“This accreditation reinforces the level of expertise and quality of care that our staff provides to people with cancer and blood disorders requiring stem cell transplantation,” said Gordon L. Phillips II, M.D., Director of the Blood and Marrow Transplant and Leukemia Program at the James P. Wilmot Cancer Center.
FACT accreditation is only awarded to centers that promote high quality patient care and laboratory research. FACT standards include a defined infrastructure for all phases of the safe collection, processing, and administration of hematopoietic cells, continual assessment of these activities, the evaluation and reporting of clinical outcomes and a quality management program.
Staff at the Samuel E. Durand Bone Marrow Transplant Unit perform about 120 transplants each year. It is the largest program in upstate New York, second only to Memorial Sloan-Kettering Cancer Center in the state.
FACT was developed by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) and has established standards for the provision of quality medical and laboratory practice in hematopoietic cell transplantation.